Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02273739
Brief Title: Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

First Submitted : October 16, 2014
First Submitted that Met QC Criteria : October 23, 2014
First Posted : October 24, 2014 (Estimate)

Certification/Extension First Submitted : November 14, 2017
Certification/Extension First Submitted that Met QC Criteria : November 14, 2017
Certification/Extension First Posted : November 17, 2017

Last Update Submitted that Met QC Criteria : October 26, 2018
Last Update Posted : October 30, 2018